Folgen
Professor S. Farajnia
Professor S. Farajnia
Sonstige NamenSafar Farajniya, S. Farajniya
Bestätigte E-Mail-Adresse bei tbzmed.ac.ir
Titel
Zitiert von
Zitiert von
Jahr
Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran
S Farajnia, MY Alikhani, R Ghotaslou, B Naghili, A Nakhlband
International journal of infectious diseases 13 (2), 140-144, 2009
3462009
Yeast expression systems: overview and recent advances
R Baghban, S Farajnia, M Rajabibazl, Y Ghasemi, AA Mafi, R Hoseinpoor, ...
Molecular biotechnology 61, 365-384, 2019
2112019
Antibody humanization methods–a review and update
Y Safdari, S Farajnia, M Asgharzadeh, M Khalili
Biotechnology and Genetic Engineering Reviews 29 (2), 175-186, 2013
2032013
The critical role of Faecalibacterium prausnitzii in human health: An overview
HE Leylabadlo, R Ghotaslou, MM Feizabadi, S Farajnia, SY Moaddab, ...
Microbial pathogenesis 149, 104344, 2020
1442020
High prevalence of metallo-β-lactamase-producing Acinetobacter baumannii in a teaching hospital in Tabriz, Iran
A Peymani, MR Nahaei, S Farajnia, A Hasani, A Mirsalehian, N Sohrabi, ...
Japanese journal of infectious diseases 64 (1), 69-71, 2011
1382011
Immunotoxins in cancer therapy: Review and update
B Akbari, S Farajnia, S Ahdi Khosroshahi, F Safari, M Yousefi, ...
International reviews of immunology 36 (4), 207-219, 2017
1352017
Natural inhibitors of PI3K/AKT signaling in breast cancer: emphasis on newly-discovered molecular mechanisms of action
Y Safdari, M Khalili, MA Ebrahimzadeh, Y Yazdani, S Farajnia
Pharmacological research 93, 1-10, 2015
1042015
Detection of metallo-β-lactamase–encoding genes among clinical isolates of Pseudomonas aeruginosa in northwest of Iran
S Yousefi, S Farajnia, MR Nahaei, MT Akhi, R Ghotaslou, MH Soroush, ...
Diagnostic microbiology and infectious disease 68 (3), 322-325, 2010
1002010
Prevalence and antibiotic resistance patterns of diarrheagenic Escherichia coli isolated from adolescents and adults in Hamedan, Western Iran
MY Alikhani, SH Hashemi, MM Aslani, S Farajnia
Iranian journal of microbiology 5 (1), 42, 2013
982013
Antibody based EpCAM targeted therapy of cancer, review and update
S Eyvazi, S Farajnia, S Dastmalchi, F Kanipour, H Zarredar, ...
Current Cancer Drug Targets 18 (9), 857-868, 2018
922018
Prevalence of OXA-Type β-Lactamases Among Acinetobacter baumannii Isolates from Northwest of Iran
N Sohrabi, S Farajnia, MT Akhi, MR Nahaei, B Naghili, A Peymani, Z Amiri, ...
Microbial drug resistance 18 (4), 385-389, 2012
852012
Prevalence of class 1 integron among multidrug-resistant Acinetobacter baumannii in Tabriz, northwest of Iran
A PEYMAnI, S FARAJnIA, MR Nahaei, N Sohrabi, L Abbasi, K Ansarin, ...
Polish Journal of Microbiology 61 (1), 57-60, 2012
852012
Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial
R Mahdavi, N Namazi, M Alizadeh, S Farajnia
Food & function 6 (6), 2041-2048, 2015
822015
Class 1 integron and imipenem resistance in clinical isolates of Pseudomonas aeruginosa: prevalence and antibiotic susceptibility
S Yousefi, MR Nahaei, S Farajnia, M Ghojazadeh, MT Akhi, Y Sharifi, ...
Iranian journal of microbiology 2 (3), 115, 2010
812010
Evolution of phage display technology: from discovery to application
L Rahbarnia, S Farajnia, H Babaei, J Majidi, K Veisi, V Ahmadzadeh, ...
Journal of drug targeting 25 (3), 216-224, 2017
802017
Prevalence of aminoglycoside resistance genes in Acinetobacter baumannii isolates
K Aliakbarzade, S Farajnia, AK Nik, F Zarei, A Tanomand
Jundishapur journal of microbiology 7 (10), 2014
782014
Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial
R Mahdavi, N Namazi, M Alizadeh, S Farajnia
Journal of clinical lipidology 10 (5), 1203-1211, 2016
762016
Oxidative Stress Responses to Nigella sativa Oil Concurrent with a Low‐Calorie Diet in Obese Women: A Randomized, Double‐Blind Controlled Clinical Trial
N Namazi, R Mahdavi, M Alizadeh, S Farajnia
Phytotherapy Research 29 (11), 1722-1728, 2015
732015
Prevalence of PER and VEB type extended spectrum betalactamases among multidrug resistant Acinetobacter baumannii isolates in North-West of Iran
S Farajnia, F Azhari, MY Alikhani, MK Hosseini, A Peymani, N Sohrabi
Iranian journal of basic medical sciences 16 (6), 751, 2013
712013
Development trends for generation of single-chain antibody fragments
S Farajnia, V Ahmadzadeh, A Tanomand, K Veisi, SA Khosroshahi, ...
Immunopharmacology and Immunotoxicology 36 (5), 297-308, 2014
672014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20